J Eur Acad Dermatol Venereol
. 2020 Jun 19.
doi: 10.1111/jdv.16760. Online ahead of print.
An Unusual Case of Bullous Hemorrhagic Vasculitis in a COVID-19 Patient
S Negrini 1 , A Guadagno 2 , M Greco 1 , A Parodi 3 , M Burlando 3
Affiliations
- PMID: 32558979
- DOI: 10.1111/jdv.16760
Abstract
A novel Coronavirus strain, named "Severe Acute Respiratory Syndrome Coronavirus 2" (SARS-CoV-2) was recently identified as the etiological agent of the COronaVIrus Disease 2019 (COVID-19). Interestingly, a consistent number of COVID-19-associated skin manifestations seem to share a certain degree of vascular damage as common pathogenetic mechanism1 . Vascular injury may be due to the direct damage of endothelial cells by the virus or may represents an epiphenomenon of a dysregulated host inflammatory responses triggered by the infection2 . Here, we describe an unprecedented case of leukocytoclastic vasculitis presenting with a hemorrhagic bullous eruption in a patient affected by COVID-19.
Keywords: COVID-19; cutaneous; cutaneous manifestations; skin.